SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped read ...

The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.

Expands pharma access to large omics datasets to advance target discovery and drug development SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced the launch of BioInsight, a ...

When Illumina (ILMN) announced its acquisition of Fluent BioSciences, it did not say how much it shelled out for the privately held single-cell technology developer in a deal that catapulted the ...

Illumina, Inc. ILMN recently announced the release of Illumina Connected Multiomics, a cloud-based research software platform to analyze and visualize multiomic and multimodal biological data at scale ...

Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial ...

During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO of Broad ...

How would it feel to know the work you do each day is impacting human health on a global scale? As genomics enables a new era of heath care, Illumina technology is empowering personalized care – ...